Use access key #2 to skip to page content.
$67.37 -0.50 (-0.74%)
7/3/2008 1:00 PM

Celgene Corp (CELG)

CAPS Rating:
*****

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

View All Commentary (CELG)

Recs

0

Avatar buysonly (29.66) Submitted: 4/23/08 6:41 PM : Outperform Start Price: $63.95 CELG Score: 13.18

Z10

Report this Post Replies: 0 | Reply

Featured Broker Partners